A detailed history of Peapack Gladstone Financial Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 28,156 shares of NVO stock, worth $3.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
28,156
Previous 24,034 17.15%
Holding current value
$3.04 Million
Previous $3.43 Million 2.27%
% of portfolio
0.05%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 26, 2024

BUY
$119.07 - $145.42 $490,806 - $599,421
4,122 Added 17.15%
28,156 $3.35 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $95,222 - $114,002
776 Added 3.34%
24,034 $3.43 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $367,902 - $489,719
3,603 Added 18.33%
23,258 $2.99 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $79,353 - $95,326
904 Added 4.82%
19,655 $2.03 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.06 Million - $2.32 Million
11,620 Added 162.95%
18,751 $1.71 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $315,703 - $349,443
2,024 Added 39.63%
7,131 $1.15 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $222,331 - $267,355
1,680 Added 49.02%
5,107 $813,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $9,024 - $11,909
88 Added 2.64%
3,427 $464,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $9,528 - $11,693
-100 Reduced 2.91%
3,339 $333,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $42,792 - $49,664
-731 Reduced 17.53%
3,439 $225,000
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $15,184 - $19,887
307 Added 7.95%
4,170 $251,000
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $192,609 - $225,058
3,863 New
3,863 $224,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.